Comment on spending more money on research into variant CJD

Navigation: Home   Comment   Education   Videos 
In November 2010, one of the latest cases of variant CJD is a man from Bosnia who needs treatment for CJD.  He came to the United Kingdom aged 5 years old to escape from the Bosnian war in 1992. This may suggest that some variant CJD was caused in 1992 or after.  

The treatment Pentosan Polisulfate (PPS) is controversial but does seem to offer hope.

This page discusses spending more money on research and treatments for variant CJD.  It has been difficult to show that it is worth spending more money on treatments; given the short life expectancy of a victim of the disease.

This leads into a discussion of the rationing of health care in the National Health Service.  Such rationing is bound to be necessary for unavoidable diseases as the country has limited resources.

However, BSE and variant CJD could have been avoided.  Debates about the rationing of variant CJD treatments should not be necessary.

If policy makers in agriculture and health had thought through the consequences of people acquiring variant CJD then this tragedy could have been avoided.   In general, policymakers need to focus on preventative policies which reduce the need for health services and health rationing later on.  

Another, hidden tragedy is that money has been spent on an avoidable disease, variant CJD, which could have been spent on other unavoidable illnesses.